Inserm is now launching a platform for evaluating vaccine candidates. The planned clinical trials are on an unprecedented scale in France.
Visit the COVIREIVAC platform website
Inserm is now launching a platform for evaluating vaccine candidates. The planned clinical trials are on an unprecedented scale in France.
Visit the COVIREIVAC platform website